ProQR Therapeutics BV Logo

ProQR Therapeutics BV (PRQR): Eigentümerstruktur

Takani Score ?
37.5

Preis (29.10.2026)52W Hoch52W Tief
1,44 US Dollar2,81 US Dollar1,2 US Dollar
Analysten KonsensBuy Outperform Hold Underperform Sell
7,778 US Dollar8 1 0 0 0
Externe Analystenschätzungen (Quelle: EODHD). Keine Anlageberatung, keine Anlageempfehlung von Takani.
#SharesShort [%] Short Ratio
141.119.0322,71 3,74

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name ProQR Therapeutics BV
Mitarbeiter 186
Handelsplatz NASDAQ
Ticker Symbol PRQR
IPO Datum 2014-09-18
Adresse Zernikedreef 9, Leiden, Netherlands, 2333 CK

Unternehmensführung

RangNamePosition
1Mr. Daniel Anton de BoerFounder, CEO & Executive Director
2Dr. Gerard Platenburg Ph.D.Co-Founder, Chief Scientific Officer & Executive Director
3Mr. Dennis HomChief Financial Officer
4Ms. Sheila SponseleeChief People & Operations Officer
5Ms. Sarah Cue KielyVice President of Investor Relations & Corporate Communications
6Dr. Cristina Lopez Lopez M.D., Ph.D.Chief Medical Officer
7Mr. Christopher Hart Ph.D.Chief Data & AI Officer
8Dr. Golnar KarimianHead of Hepatology
9Ms. Sandra van der KolkJunior Financial Controller

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1Adage Capital Partners Gp LLC6,39%12,71 Mio. USD
2Aberdeen Group PLC6,33%12,60 Mio. USD
3Affinity Asset Advisors, LLC3,93%7,82 Mio. USD
4Privium Fund Management B.V.3,91%7,78 Mio. USD
5Ikarian Capital, LLC2,43%4,83 Mio. USD
6Woodline Partners LP2,32%4,62 Mio. USD
7Heights Capital Management Inc1,96%3,90 Mio. USD
8Morgan Stanley - Brokerage Accounts1,25%2,49 Mio. USD
9Sphera Funds Management Ltd.1,25%2,48 Mio. USD
10Kynam Capital Management, LP1,11%2,21 Mio. USD
11Dafna Capital Management LLC1,08%2,16 Mio. USD
12Squadron Capital Management LLC1,07%2,13 Mio. USD
13Junked Platinum Investment Management Ltd0,88%1,74 Mio. USD
14Citadel Advisors Llc0,84%1,67 Mio. USD
15Two Sigma Investments LLC0,81%1,61 Mio. USD
16Eversept Partners, LP0,72%1,44 Mio. USD
17BOOTHBAY FUND MANAGEMENT, LLC0,67%1,34 Mio. USD
18Diadema Partners LP0,66%1,31 Mio. USD
19UBS Group AG0,45%0,90 Mio. USD
20Delaware Management Holdings Inc0,44%0,87 Mio. USD